Does the media prefer IDXX or GMED?

In the previous week, Globus Medical had 5 more articles in the media than IDEXX Laboratories. MarketBeat recorded 12 mentions for Globus Medical and 7 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.32 beat Globus Medical's score of 1.17 indicating that IDEXX Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Globus Medical 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, GMED or DXCM?

DexCom has higher revenue and earnings than Globus Medical. Globus Medical is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Globus Medical $2.94B 3.77 $537.87M $3.91 21.12 DexCom $4.97B 6.78 $836.30M $2.53 35.29

Is GMED or DXCM more profitable?

DexCom has a net margin of 20.12% compared to Globus Medical's net margin of 17.02%. DexCom's return on equity of 35.94% beat Globus Medical's return on equity. Company Net Margins Return on Equity Return on Assets Globus Medical 17.02% 14.57% 12.62% DexCom 20.12% 35.94% 14.75%

Does the media favor GMED or DXCM?

In the previous week, DexCom had 15 more articles in the media than Globus Medical. MarketBeat recorded 27 mentions for DexCom and 12 mentions for Globus Medical. DexCom's average media sentiment score of 1.63 beat Globus Medical's score of 1.17 indicating that DexCom is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Globus Medical 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 25 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media prefer GEHC or GMED?

In the previous week, GE HealthCare Technologies had 8 more articles in the media than Globus Medical. MarketBeat recorded 20 mentions for GE HealthCare Technologies and 12 mentions for Globus Medical. Globus Medical's average media sentiment score of 1.17 beat GE HealthCare Technologies' score of 1.13 indicating that Globus Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GE HealthCare Technologies 16 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Globus Medical 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, RMD or GMED?

ResMed has higher revenue and earnings than Globus Medical. Globus Medical is trading at a lower price-to-earnings ratio than ResMed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ResMed $5.65B 6.01 $1.52B $10.43 22.59 Globus Medical $2.94B 3.77 $537.87M $3.91 21.12

Is RMD or GMED more profitable?

ResMed has a net margin of 26.94% compared to Globus Medical's net margin of 17.02%. ResMed's return on equity of 25.58% beat Globus Medical's return on equity. Company Net Margins Return on Equity Return on Assets ResMed 26.94% 25.58% 18.89% Globus Medical 17.02% 14.57% 12.62%

Does the media refer more to RMD or GMED?

In the previous week, ResMed had 23 more articles in the media than Globus Medical. MarketBeat recorded 35 mentions for ResMed and 12 mentions for Globus Medical. ResMed's average media sentiment score of 1.41 beat Globus Medical's score of 1.17 indicating that ResMed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ResMed 27 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Globus Medical 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate PHG or GMED?

Globus Medical has a consensus target price of $101.77, indicating a potential upside of 23.25%. Given Globus Medical's stronger consensus rating and higher possible upside, analysts plainly believe Globus Medical is more favorable than Koninklijke Philips. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Koninklijke Philips 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Globus Medical 0 Sell rating(s) 5 Hold rating(s) 9 Buy rating(s) 3 Strong Buy rating(s) 2.88

Does the media refer more to PHG or GMED?

In the previous week, Globus Medical had 5 more articles in the media than Koninklijke Philips. MarketBeat recorded 12 mentions for Globus Medical and 7 mentions for Koninklijke Philips. Globus Medical's average media sentiment score of 1.17 beat Koninklijke Philips' score of 0.63 indicating that Globus Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Koninklijke Philips 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Globus Medical 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Globus Medical (GMED) Competitors

$82.10 -0.44 (-0.53%)

As of 10:15 AM Eastern

Compare

GMED vs. IDXX, DXCM, GEHC, RMD, and PHG

Should you buy Globus Medical stock or one of its competitors? Globus Medical's main competitors and comparable companies include IDEXX Laboratories (IDXX), DexCom (DXCM), GE HealthCare Technologies (GEHC), ResMed (RMD), and Koninklijke Philips (PHG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Globus Medical compare to IDEXX Laboratories?

IDEXX Laboratories (NASDAQ:IDXX) and Globus Medical (NYSE:GMED) are both large-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, profitability, earnings, institutional ownership, dividends and media sentiment.

IDEXX Laboratories has a beta of 1.54, meaning that its stock price is 54% more volatile than the broader market. Comparatively, Globus Medical has a beta of 0.95, meaning that its stock price is 5% less volatile than the broader market.

IDEXX Laboratories has a net margin of 25.03% compared to Globus Medical's net margin of 17.02%. IDEXX Laboratories' return on equity of 71.96% beat Globus Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	25.03%	71.96%	33.60%
Globus Medical	17.02%	14.57%	12.62%

IDEXX Laboratories has higher revenue and earnings than Globus Medical. Globus Medical is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.55B	9.43	$1.06B	$14.22	38.33
Globus Medical	$2.94B	3.77	$537.87M	$3.91	21.12

87.8% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 95.2% of Globus Medical shares are owned by institutional investors. 0.8% of IDEXX Laboratories shares are owned by company insiders. Comparatively, 18.4% of Globus Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Globus Medical had 5 more articles in the media than IDEXX Laboratories. MarketBeat recorded 12 mentions for Globus Medical and 7 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.32 beat Globus Medical's score of 1.17 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Globus Medical	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

IDEXX Laboratories currently has a consensus target price of $747.00, suggesting a potential upside of 37.06%. Globus Medical has a consensus target price of $101.77, suggesting a potential upside of 23.25%. Given IDEXX Laboratories' higher probable upside, analysts plainly believe IDEXX Laboratories is more favorable than Globus Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.88

Summary

IDEXX Laboratories beats Globus Medical on 11 of the 17 factors compared between the two stocks.

How does Globus Medical compare to DexCom?

Globus Medical (NYSE:GMED) and DexCom (NASDAQ:DXCM) are both large-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, media sentiment, profitability, dividends, analyst recommendations and valuation.

Globus Medical has a beta of 0.95, meaning that its share price is 5% less volatile than the broader market. Comparatively, DexCom has a beta of 1.41, meaning that its share price is 41% more volatile than the broader market.

95.2% of Globus Medical shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 18.4% of Globus Medical shares are owned by company insiders. Comparatively, 0.3% of DexCom shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

DexCom has higher revenue and earnings than Globus Medical. Globus Medical is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Globus Medical	$2.94B	3.77	$537.87M	$3.91	21.12
DexCom	$4.97B	6.78	$836.30M	$2.53	35.29

DexCom has a net margin of 20.12% compared to Globus Medical's net margin of 17.02%. DexCom's return on equity of 35.94% beat Globus Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Globus Medical	17.02%	14.57%	12.62%
DexCom	20.12%	35.94%	14.75%

Globus Medical presently has a consensus target price of $101.77, indicating a potential upside of 23.25%. DexCom has a consensus target price of $88.71, indicating a potential downside of 0.65%. Given Globus Medical's higher possible upside, equities research analysts plainly believe Globus Medical is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.88
DexCom	1 Sell rating(s)	3 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.89

In the previous week, DexCom had 15 more articles in the media than Globus Medical. MarketBeat recorded 27 mentions for DexCom and 12 mentions for Globus Medical. DexCom's average media sentiment score of 1.63 beat Globus Medical's score of 1.17 indicating that DexCom is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Globus Medical	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DexCom	25 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

DexCom beats Globus Medical on 13 of the 17 factors compared between the two stocks.

How does Globus Medical compare to GE HealthCare Technologies?

GE HealthCare Technologies (NASDAQ:GEHC) and Globus Medical (NYSE:GMED) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings, dividends and media sentiment.

GE HealthCare Technologies has higher revenue and earnings than Globus Medical. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GE HealthCare Technologies	$21.27B	1.55	$2.08B	$4.36	16.69
Globus Medical	$2.94B	3.77	$537.87M	$3.91	21.12

Globus Medical has a net margin of 17.02% compared to GE HealthCare Technologies' net margin of 9.33%. GE HealthCare Technologies' return on equity of 20.12% beat Globus Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GE HealthCare Technologies	9.33%	20.12%	5.74%
Globus Medical	17.02%	14.57%	12.62%

82.1% of GE HealthCare Technologies shares are owned by institutional investors. Comparatively, 95.2% of Globus Medical shares are owned by institutional investors. 0.4% of GE HealthCare Technologies shares are owned by insiders. Comparatively, 18.4% of Globus Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

GE HealthCare Technologies has a beta of 0.69, meaning that its share price is 31% less volatile than the broader market. Comparatively, Globus Medical has a beta of 0.95, meaning that its share price is 5% less volatile than the broader market.

In the previous week, GE HealthCare Technologies had 8 more articles in the media than Globus Medical. MarketBeat recorded 20 mentions for GE HealthCare Technologies and 12 mentions for Globus Medical. Globus Medical's average media sentiment score of 1.17 beat GE HealthCare Technologies' score of 1.13 indicating that Globus Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GE HealthCare Technologies	16 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Globus Medical	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

GE HealthCare Technologies presently has a consensus price target of $77.73, indicating a potential upside of 6.78%. Globus Medical has a consensus price target of $101.77, indicating a potential upside of 23.25%. Given Globus Medical's stronger consensus rating and higher possible upside, analysts clearly believe Globus Medical is more favorable than GE HealthCare Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GE HealthCare Technologies	0 Sell rating(s)	11 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.48
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.88

Summary

Globus Medical beats GE HealthCare Technologies on 11 of the 17 factors compared between the two stocks.

How does Globus Medical compare to ResMed?

ResMed (NYSE:RMD) and Globus Medical (NYSE:GMED) are both large-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, risk, profitability, media sentiment and valuation.

ResMed has a net margin of 26.94% compared to Globus Medical's net margin of 17.02%. ResMed's return on equity of 25.58% beat Globus Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ResMed	26.94%	25.58%	18.89%
Globus Medical	17.02%	14.57%	12.62%

In the previous week, ResMed had 23 more articles in the media than Globus Medical. MarketBeat recorded 35 mentions for ResMed and 12 mentions for Globus Medical. ResMed's average media sentiment score of 1.41 beat Globus Medical's score of 1.17 indicating that ResMed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ResMed	27 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Globus Medical	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

ResMed has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market. Comparatively, Globus Medical has a beta of 0.95, indicating that its share price is 5% less volatile than the broader market.

ResMed has higher revenue and earnings than Globus Medical. Globus Medical is trading at a lower price-to-earnings ratio than ResMed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ResMed	$5.65B	6.01	$1.52B	$10.43	22.59
Globus Medical	$2.94B	3.77	$537.87M	$3.91	21.12

ResMed currently has a consensus target price of $239.38, indicating a potential upside of 1.59%. Globus Medical has a consensus target price of $101.77, indicating a potential upside of 23.25%. Given Globus Medical's stronger consensus rating and higher probable upside, analysts clearly believe Globus Medical is more favorable than ResMed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ResMed	0 Sell rating(s)	10 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.41
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.88

55.0% of ResMed shares are owned by institutional investors. Comparatively, 95.2% of Globus Medical shares are owned by institutional investors. 0.7% of ResMed shares are owned by insiders. Comparatively, 18.4% of Globus Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

ResMed beats Globus Medical on 10 of the 17 factors compared between the two stocks.

How does Globus Medical compare to Koninklijke Philips?

Koninklijke Philips (NYSE:PHG) and Globus Medical (NYSE:GMED) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

13.7% of Koninklijke Philips shares are owned by institutional investors. Comparatively, 95.2% of Globus Medical shares are owned by institutional investors. 18.4% of Globus Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Globus Medical has a consensus target price of $101.77, indicating a potential upside of 23.25%. Given Globus Medical's stronger consensus rating and higher possible upside, analysts plainly believe Globus Medical is more favorable than Koninklijke Philips.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Koninklijke Philips	0 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Globus Medical	0 Sell rating(s)	5 Hold rating(s)	9 Buy rating(s)	3 Strong Buy rating(s)	2.88

Koninklijke Philips has higher revenue and earnings than Globus Medical. Koninklijke Philips is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Koninklijke Philips	$17.67B	1.50	$1.01B	$1.36	19.76
Globus Medical	$2.94B	3.77	$537.87M	$3.91	21.12

Globus Medical has a net margin of 17.02% compared to Koninklijke Philips' net margin of 6.30%. Globus Medical's return on equity of 14.57% beat Koninklijke Philips' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Koninklijke Philips	6.30%	14.38%	5.96%
Globus Medical	17.02%	14.57%	12.62%

In the previous week, Globus Medical had 5 more articles in the media than Koninklijke Philips. MarketBeat recorded 12 mentions for Globus Medical and 7 mentions for Koninklijke Philips. Globus Medical's average media sentiment score of 1.17 beat Koninklijke Philips' score of 0.63 indicating that Globus Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Koninklijke Philips	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Globus Medical	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Koninklijke Philips has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market. Comparatively, Globus Medical has a beta of 0.95, meaning that its stock price is 5% less volatile than the broader market.

Summary

Globus Medical beats Koninklijke Philips on 15 of the 17 factors compared between the two stocks.

Get Globus Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GMED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GMED vs. The Competition

Export

Metric	Globus Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$11.09B	$5.90B	$7.32B	$24.31B
Dividend Yield	N/A	1.75%	2.53%	3.71%
P/E Ratio	21.12	25.97	271.28	30.24
Price / Sales	3.77	79.79	693.41	17.39
Price / Cash	13.23	33.01	79.17	33.18
Price / Book	2.32	6.20	13.02	7.68
Net Income	$537.87M	$149.10M	$3.46B	$1.07B
7 Day Performance	-4.88%	-0.19%	1.01%	-0.30%
1 Month Performance	2.59%	7.49%	8.62%	1.63%
1 Year Performance	35.01%	6.10%	26.56%	14.07%

Globus Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GMED Globus Medical	4.5374 of 5 stars	$82.11 -0.5%	$101.77 +23.9%	+34.2%	$11.02B	$2.94B	21.00	6,000	Trending News Analyst Revision
IDXX IDEXX Laboratories	4.4504 of 5 stars	$546.09 -0.9%	$747.00 +36.8%	-14.9%	$43.41B	$4.30B	38.40	11,000	Positive News
DXCM DexCom	4.3276 of 5 stars	$88.76 -1.1%	$88.71 -0.1%	+16.9%	$33.87B	$4.66B	35.08	11,000	Positive News
GEHC GE HealthCare Technologies	4.2051 of 5 stars	$72.37 -1.8%	$77.73 +7.4%	-2.4%	$33.28B	$20.63B	16.60	54,000
RMD ResMed	4.3886 of 5 stars	$220.37 -1.8%	$240.17 +9.0%	-16.4%	$32.56B	$5.65B	21.13	11,370	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:GMED) was last updated on 8/28/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Globus Medical (GMED) Competitors

GMED vs. IDXX, DXCM, GEHC, RMD, and PHG

How does Globus Medical compare to IDEXX Laboratories?

Summary

How does Globus Medical compare to DexCom?

Summary

How does Globus Medical compare to GE HealthCare Technologies?

Summary

How does Globus Medical compare to ResMed?

Summary

How does Globus Medical compare to Koninklijke Philips?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GMED vs. The Competition

Globus Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Globus Medical (GMED) Competitors

GMED vs. IDXX, DXCM, GEHC, RMD, and PHG

How does Globus Medical compare to IDEXX Laboratories?

Which has more risk and volatility, IDXX or GMED?

Is IDXX or GMED more profitable?

Which has preferable valuation & earnings, IDXX or GMED?

Do insiders and institutionals hold more shares of IDXX or GMED?

Does the media prefer IDXX or GMED?

Do analysts rate IDXX or GMED?

Summary

How does Globus Medical compare to DexCom?

Which has more risk and volatility, GMED or DXCM?

Do insiders & institutionals have more ownership in GMED or DXCM?

Which has higher valuation and earnings, GMED or DXCM?

Is GMED or DXCM more profitable?

Do analysts prefer GMED or DXCM?

Does the media favor GMED or DXCM?

Summary

How does Globus Medical compare to GE HealthCare Technologies?

Which has better earnings and valuation, GEHC or GMED?

Is GEHC or GMED more profitable?

Do insiders & institutionals believe in GEHC or GMED?

Which has more volatility and risk, GEHC or GMED?

Does the media prefer GEHC or GMED?

Do analysts recommend GEHC or GMED?

Summary

How does Globus Medical compare to ResMed?

Is RMD or GMED more profitable?

Does the media refer more to RMD or GMED?

Which has more risk & volatility, RMD or GMED?

Which has higher earnings and valuation, RMD or GMED?

Do analysts rate RMD or GMED?

Do insiders & institutionals believe in RMD or GMED?

Summary

How does Globus Medical compare to Koninklijke Philips?

Do institutionals and insiders have more ownership in PHG or GMED?

Do analysts rate PHG or GMED?

Which has stronger valuation and earnings, PHG or GMED?

Is PHG or GMED more profitable?

Does the media refer more to PHG or GMED?

Which has more volatility & risk, PHG or GMED?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GMED vs. The Competition

Globus Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools